Financials
- Market Capitalization 319.85 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3222 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +9.05% | +36.16% | 336.28 M USD | ||
| 3260 | IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +22.00% | -11.52% | 322.84 M USD | ||
| 3294 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +35.51% | +92.22% | 311.95 M USD | ||
| 3308 | IRD Opus Genetics, Inc. - Common Stock | 3.69 USD | -4.16% | -8.21% | +6.65% | -0.81% | 306.99 M USD |
Frequently asked questions about Vanda Pharmaceuticals Inc.
What is the Vanda Pharmaceuticals Inc. stock price today?
The current price of Vanda Pharmaceuticals Inc. (VNDA) is 5.29. Over the past 24 hours, the stock has changed by -2.76%. Follow the VNDA chart for real-time price dynamics.
What is the stock ticker of Vanda Pharmaceuticals Inc.?
Vanda Pharmaceuticals Inc. trades under the ticker VNDA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vanda Pharmaceuticals Inc. stock going up?
VNDA has changed by -0.94% over the last week, +4.13% over the last month, and -4.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vanda Pharmaceuticals Inc.?
Vanda Pharmaceuticals Inc. currently has a market capitalization of 319.85 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vanda Pharmaceuticals Inc. earnings last quarter?
Last quarter, Vanda Pharmaceuticals Inc. reported earnings of -1.04 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vanda Pharmaceuticals Inc. revenue for the last quarter?
Vanda Pharmaceuticals Inc. reported quarterly revenue of 50.53 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vanda Pharmaceuticals Inc. net income for the last quarter?
Vanda Pharmaceuticals Inc. reported net income of -62.51 M for the last quarter. The previous quarter showed -48.57 M, which means net income changed by -28.71%.
How many employees does Vanda Pharmaceuticals Inc. have?
As of the latest available data, Vanda Pharmaceuticals Inc. has 533 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vanda Pharmaceuticals Inc. EBITDA?
Vanda Pharmaceuticals Inc. EBITDA is -61.55 M, and its EBITDA margin is -121.82%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vanda Pharmaceuticals Inc. stock?
You can buy Vanda Pharmaceuticals Inc. (VNDA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vanda Pharmaceuticals Inc. stock?
Investing in Vanda Pharmaceuticals Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VNDA chart and related analysis on metatrader.com as part of your research.